CACHEXIA-ANOREXIA SYNDROME
Clinical trials for CACHEXIA-ANOREXIA SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CACHEXIA-ANOREXIA SYNDROME trials appear
Sign up with your email to follow new studies for CACHEXIA-ANOREXIA SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common mental health drug prevent weight loss in cancer patients?
Symptom relief Recruiting nowThis study is testing whether a low dose of olanzapine, a drug usually used for mental health conditions, can prevent or treat the loss of appetite and weight that often happens in cancer patients receiving chemotherapy. About 100 adults with stomach or ovarian cancer will take t…
Matched conditions: CACHEXIA-ANOREXIA SYNDROME
Phase: PHASE3 • Sponsor: Blokhin's Russian Cancer Research Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New injection aims to help cancer patients eat and gain weight
Symptom relief Recruiting nowThis early-stage study tests a new injection called SXRN in 54 cancer patients who have lost their appetite and weight due to their illness. The main goal is to see if the drug is safe and to find the best dose. Researchers will also check if it helps improve appetite and weight …
Matched conditions: CACHEXIA-ANOREXIA SYNDROME
Phase: PHASE1 • Sponsor: Jiangsu Nutai Biologics Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC